FIELD: immunology.
SUBSTANCE: disclosed is a method of producing an antibody or fragment thereof.
EFFECT: present invention can find further application in production of such an antibody as Ranibizumab.
3 cl, 7 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| Fab FRAGMENT OF HUMANIZED ANTIBODY AGAINST VEGF AND ITS USE | 2020 |
|
RU2802960C2 |
| POLYPEPTIDE LINKER FOR PRODUCTION OF MULTI-SPECIFIC ANTIBODIES | 2018 |
|
RU2776302C2 |
| ANTIBODIES AGAINST PROGRAMMED CELL DEATH LIGAND 1 AND THEIR USE | 2020 |
|
RU2786235C1 |
| COMPOSITIONS OF ANTIBODIES AGAINST ROR1 AND CORRESPONDING METHODS | 2017 |
|
RU2766190C2 |
| MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THIOREDOXIN-1 AND ITS USE | 2016 |
|
RU2747929C2 |
| ANTIBODIES AGAINST VISTA AND APPLICATION THEREOF | 2018 |
|
RU2750723C1 |
| LIBRARY OF CONCENTRATION-DEPENDENT BINDING MOLECULES | 2012 |
|
RU2732151C2 |
| NEW ANTI-IL13 ANTIBODIES AND USE THEREOF | 2020 |
|
RU2752833C1 |
| ANTIBODY TO IL-13RA2 AND ITS APPLICATION | 2018 |
|
RU2756623C2 |
| BISPECIFIC ANTIGEN-BINDING MOLECULES CONTAINING ANTI-FAP CLONE 212 | 2019 |
|
RU2799429C2 |
